Abstract
Neurofibromatosis (NF) type 1, also known as von Recklinghausen’s disease, is an autosomal-dominant inherited disorder. Some tumors may develop in these patients, including optic pathway gliomas, astrocytomas, brainstem gliomas, chronic myeloid leukemia, and rhabdomyosarcoma. Patients with neurofibromatosis type 1 show also an increased risk of endocrine tumors, especially pheochromocytomas, whereas thyroid carcinoma is very rare. It is also rare for a neurofibroma to arise in the tissue neighboring the thyroid gland, and mimicking a nonfunctional thyroid nodule. This report presents a case of a neurofibroma adherent to the thyroid gland with thyroid papillary carcinoma in a 26-year-old woman with NF type 1.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ferner RE. Neurofibromatosis 1. Eur J Hum Genet 2007;15:131–138.
Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis. J Med Genet 2007;44:81–88.
Nakamura H, Koga M, Higa S, Sato B, Noma K, Morimoto Y, et al. A case of von Recklinghausen’s disease associated with pheochromocytoma and papillary carcinoma of the thyroid gland. Endocrinol Jpn 1987;34:545–551.
Hashiba T, Maruno M, Fujimoto Y, Suzuki T, Wada K, Isaka T, et al. Skull metastasis from papillary thyroid carcinoma accompanied by neurofibromatosis type 1 and pheochromocytoma: report of a case. Brain Tumor Pathol 2006;23:97–100.
Hasegawa M, Tanaka H, Watanabe I, Uehara T, Nasu M. Malignant schwannoma and follicular thyroid carcinoma associated with von Recklinghausen’s disease. J Laryngol Otol 1984;98:1057–1061.
Anagnostouli M, Piperingos G, Yapijakis C, Gourtzelidis P, Balafouta S, Zournas C, et al. Thyroid gland neurofibroma in a NF1 patient. Acta Neurol Scand 2002;106:58–61.
Severo MD, da Rosa VD, De Carli DM, de Oliveira Beck M, Danbermam MF. Neurofibroma of thyroid in a patient with neurofibromatosis type 1. Arq Bras Endocrinol Metab 2008;52:131–133.
Ciardi A, Pecorella I, Trombetta G, Memeo L, Quarto AD, Tondo UD. An unusual case of neurofibroma of the thyroid capsule. Pathol Oncol Res 1997;3:293–295.
Fotaki P, Michailidis E, Vitoratos N, Deligeoroglou E, Kokkalis D, Creatsas G. von Recklinghausen’s disease and pregnancy. Akush Ginekol (Sofia). 2002;42:15–16.
Carta C, Moretti S, Passeri L, Barbi F, Avenia N, Cavaliere A, et al. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Clin Endocrinol (Oxf) 2006;64:105–109.
Goutas N, Vlachodimitropoulos D, Bouka M, Lazaris AC, Nasioulas G, Gazouli M. BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort. Anticancer Res 2008;28:305–308.
Brzeziańska E, Pastuszak-Lewandoska D, Wojciechowska K, Migdalska-Sek M, Cyniak-Magierska A, Nawrot E, et al. Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population. Neuroendocrinol Lett 2007;28:351–359.
Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res 2003;63:4561–4567.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koksal, Y., Sahin, M., Koksal, H. et al. Neurofibroma adjacent to the thyroid gland and a thyroid papillary carcinoma in a patient with neurofibromatosis type 1: Report of a case. Surg Today 39, 884–887 (2009). https://doi.org/10.1007/s00595-008-3946-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-008-3946-9